Optinose to be acquired by Boston-based Paratek Pharmaceuticals in potential $330M deal
The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...
Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake
Shares in the consumer health group - originally a joint venture between Pfizer and GSK - are up nearly a fifth since it ...
From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
BioPharma Dive12d
Ono pays $280M to license Ionis rare disease drug
Ionis’ drug, called sapablursen, is currently being tested in a Phase 2 trial in people with polycythemia vera.
Business Wire13d
Ionis and Ono announce global license agreement for sapablursen in polycythemia vera
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced that the two companies have ...
Ionis Pharmaceuticals and Ono announce license agreement for sapablursen
Ionis Pharmaceuticals (IONS) and Ono Pharmaceutical announced that the two companies have entered into a license agreement in which Ono obtains ...
Indiatimes18d
Oxygenta Pharmaceutical Updates on Open Offer
As many as five current and former officials of Add-Shop E-Retail Ltd (ASERL) and White Organic Agro Ltd (WOAL) on Thursday settled a case with Sebi pertaining violation of regulatory norms and made a ...
Equity Bulls19d
AXISCADES' subsidiary Mistral and Altera Forge Strategic Alliance
Mistral Solutions Private Ltd, (Mistral) a subsidiary of AXISCADES Technologies Limited (AXISCADES), a chip to product company and a pioneer in Defense, Electronics, Semiconductor and Artificial ...